CONMED Corporation Announces Quarterly Cash Dividend

Rhea-AI Summary

CONMED Corporation (NYSE: CNMD) has declared a quarterly cash dividend of $0.20 per share. The dividend is payable on April 5, 2023, to shareholders of record as of March 15, 2023. This announcement reflects the company's ongoing commitment to returning value to its shareholders.

CONMED specializes in providing surgical devices and equipment for minimally invasive procedures in various medical specialties, including orthopedics and gastroenterology. Further details can be found on their official website.

Positive

• Quarterly cash dividend of $0.20 per share announced.
• Dividend payment demonstrates commitment to shareholder value.

Negative

• Potential risks from COVID-19 impacting surgical procedures.
• Uncertainties in supply chain reliability affecting operations.

LARGO, Fla.--(BUSINESS WIRE)--

CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on April 5, 2023, to all shareholders of record as of March 15, 2023.

About CONMED Corporation

CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company’s products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. For more information, visit www.conmed.com.

Forward-Looking Statements

This press release may contain forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties, which could cause actual results, performance, or trends to differ materially from those expressed in the forward-looking statements herein or in previous disclosures. For example, in addition to general industry and economic conditions, factors that could cause actual results to differ materially from those in the forward-looking statements may include, but are not limited to, the risks posed to the Company’s business, financial condition, and results of operations by the COVID-19 global pandemic and the various government responses to the pandemic, including deferral of surgeries, reductions in hospital and ambulatory surgery center operating volumes, disruption to potential supply chain reliability; any assumptions underlying any of the foregoing as well as the risk factors discussed in the Company's Annual Report on Form 10-K for the full year ended December 31, 2022, listed under the heading Forward-Looking Statements in the Company’s most recently filed Form 10-K and other risks and uncertainties which may be detailed from time to time in reports filed by CONMED with the SEC. Any and all forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company’s performance on a going-forward basis. The Company believes that all forward-looking statements made by it have a reasonable basis, but there can be no assurance that management’s expectations, beliefs or projections as expressed in the forward-looking statements will actually occur or prove to be correct.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230227005807/en/

CONMED Corporation

Todd Garner

Chief Financial Officer

727-214-2975

ToddGarner@conmed.com

Source: CONMED Corporation

FAQ

What is the dividend amount declared by CONMED Corporation?

CONMED Corporation declared a quarterly cash dividend of $0.20 per share.

When will the dividend be paid to shareholders of CONMED Corporation?

The dividend will be payable on April 5, 2023.

What is the record date for the CONMED Corporation dividend?

The record date for the dividend is March 15, 2023.

What potential risks could affect CONMED Corporation's performance?

The COVID-19 pandemic and disrupted supply chains pose risks to CONMED's operations.